BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31499509)

  • 1. Androgens in Menopausal Women: Not Only Polycystic Ovary Syndrome.
    Kostakis EK; Gkioni LN; Macut D; Mastorakos G
    Front Horm Res; 2019; 53():135-161. PubMed ID: 31499509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
    Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
    Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
    Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B; Tworowska U; Demissie M; Milewicz A
    Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hyperandrogenism.
    Yoldemir T
    Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.
    Zhou R; Bird IM; Dumesic DA; Abbott DH
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6630-7. PubMed ID: 16174719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.
    Rosenfield RL; Mortensen M; Wroblewski K; Littlejohn E; Ehrmann DA
    Hum Reprod; 2011 Nov; 26(11):3138-46. PubMed ID: 21908468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral Adrenal Hyperplasia as a Possible Mechanism for Hyperandrogenism in Women With Polycystic Ovary Syndrome.
    Gourgari E; Lodish M; Keil M; Sinaii N; Turkbey E; Lyssikatos C; Nesterova M; de la Luz Sierra M; Xekouki P; Khurana D; Ten S; Dobs A; Stratakis CA
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3353-60. PubMed ID: 27336356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian and adrenal hyperandrogenism.
    Carmina E
    Ann N Y Acad Sci; 2006 Dec; 1092():130-7. PubMed ID: 17308139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D; Leigh A; Wilson C; Donaldson A; Franks S
    Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adrenal and polycystic ovary syndrome.
    Yildiz BO; Azziz R
    Rev Endocr Metab Disord; 2007 Dec; 8(4):331-42. PubMed ID: 17932770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism.
    Auer MK; Hawley JM; Lottspeich C; Bidlingmaier M; Sappl A; Nowotny HF; Tschaidse L; Treitl M; Reincke M; Keevil BG; Reisch N
    Eur J Endocrinol; 2022 Dec; 187(6):K47-K53. PubMed ID: 36239921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
    Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovarian disease: the adrenal connection.
    Marouliss GB; Triantafillidis IK
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():205-7. PubMed ID: 16641861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.